Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A woman with severe angioedema improved significantly after treatment with rituximab.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Baricitinib is the most effective treatment for alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.